[prêmio] CFFT Therapeutic Development Awards
14/09/2017 16:07
Objetivo:
The Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) Therapeutics Development Award (TDA) program is designed to stimulate businesses to pursue novel therapies for cystic fibrosis by filling the gap between basic research and Phase 3 clinical trials. The program provides companies with funding and other resources to support studies that may include drug discovery, pre-clinical safety, PK/PD, and ADME testing through early safety and efficacy trials in patients.
Inscrições:
até dia 31 de outubro de 2017.
Mais informações no site.
